Analysis of Key Genes and miRNA-mRNA Networks Associated with Glucocorticoids Treatment in Chronic Obstructive Pulmonary Disease

IF 2.8 3区 医学 Q1 Medicine
Jian-Jun Wu, Ping-An Zhang, Ming-Zhe Chen, Yi Zhang, Wei-Sha Du, Xiao-Ning Li, Guo-Chao Ji, Liang-Duo Jiang, Yang Jiao, Xin Li
{"title":"Analysis of Key Genes and miRNA-mRNA Networks Associated with Glucocorticoids Treatment in Chronic Obstructive Pulmonary Disease","authors":"Jian-Jun Wu, Ping-An Zhang, Ming-Zhe Chen, Yi Zhang, Wei-Sha Du, Xiao-Ning Li, Guo-Chao Ji, Liang-Duo Jiang, Yang Jiao, Xin Li","doi":"10.2147/copd.s441716","DOIUrl":null,"url":null,"abstract":"<strong>Background:</strong> Some patients with chronic obstructive pulmonary disease (COPD) benefit from glucocorticoid (GC) treatment, but its mechanism is unclear.<br/><strong>Objective:</strong> With the help of the Gene Expression Omnibus (GEO) database, the key genes and miRNA-mRNA related to the treatment of COPD by GCs were discussed, and the potential mechanism was explained.<br/><strong>Methods:</strong> The miRNA microarray dataset (GSE76774) and mRNA microarray dataset (GSE36221) were downloaded, and differential expression analysis were performed. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on the differentially expressed genes (DEGs). The protein interaction network of the DEGs in the regulatory network was constructed with the STRING database, and the key genes were screened through Cytoscape. Potential downstream target genes regulated by differentially expressed miRNAs (DEMs) were predicted by the miRWalk3.0 database, and miRNA-mRNA regulatory networks were constructed. Finally, some research results were validated.<br/><strong>Results:</strong> ① Four DEMs and 83 DEGs were screened; ② GO and KEGG enrichment analysis mainly focused on the PI3K/Akt signalling pathway, ECM receptor interaction, etc.; ③ CD2, SLAMF7, etc. may be the key targets of GC in the treatment of COPD; ④ 18 intersection genes were predicted by the mirwalk 3.0 database, and 9 pairs of miRNA-mRNA regulatory networks were identified; ⑤ The expression of miR-320d-2 and TFCP2L1 were upregulated by dexamethasone in the COPD cell model, while the expression of miR-181a-2-3p and SLAMF7 were downregulated.<br/><strong>Conclusion:</strong> In COPD, GC may mediate the expression of the PI3K/Akt signalling pathway through miR-181a-2-3p, miR-320d-2, miR-650, and miR-155-5p, targeting its downstream signal factors. The research results provide new ideas for RNA therapy strategies of COPD, and also lay a foundation for further research.<br/><br/>","PeriodicalId":13792,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/copd.s441716","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Some patients with chronic obstructive pulmonary disease (COPD) benefit from glucocorticoid (GC) treatment, but its mechanism is unclear.
Objective: With the help of the Gene Expression Omnibus (GEO) database, the key genes and miRNA-mRNA related to the treatment of COPD by GCs were discussed, and the potential mechanism was explained.
Methods: The miRNA microarray dataset (GSE76774) and mRNA microarray dataset (GSE36221) were downloaded, and differential expression analysis were performed. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on the differentially expressed genes (DEGs). The protein interaction network of the DEGs in the regulatory network was constructed with the STRING database, and the key genes were screened through Cytoscape. Potential downstream target genes regulated by differentially expressed miRNAs (DEMs) were predicted by the miRWalk3.0 database, and miRNA-mRNA regulatory networks were constructed. Finally, some research results were validated.
Results: ① Four DEMs and 83 DEGs were screened; ② GO and KEGG enrichment analysis mainly focused on the PI3K/Akt signalling pathway, ECM receptor interaction, etc.; ③ CD2, SLAMF7, etc. may be the key targets of GC in the treatment of COPD; ④ 18 intersection genes were predicted by the mirwalk 3.0 database, and 9 pairs of miRNA-mRNA regulatory networks were identified; ⑤ The expression of miR-320d-2 and TFCP2L1 were upregulated by dexamethasone in the COPD cell model, while the expression of miR-181a-2-3p and SLAMF7 were downregulated.
Conclusion: In COPD, GC may mediate the expression of the PI3K/Akt signalling pathway through miR-181a-2-3p, miR-320d-2, miR-650, and miR-155-5p, targeting its downstream signal factors. The research results provide new ideas for RNA therapy strategies of COPD, and also lay a foundation for further research.

与慢性阻塞性肺病糖皮质激素治疗相关的关键基因和 miRNA-mRNA 网络分析
背景:一些慢性阻塞性肺病(COPD)患者从糖皮质激素(GC)治疗中获益,但其机制尚不清楚:一些慢性阻塞性肺病(COPD)患者从糖皮质激素(GC)治疗中获益,但其机制尚不清楚:借助基因表达总库(GEO)数据库,探讨与糖皮质激素治疗慢性阻塞性肺病相关的关键基因和miRNA-mRNA,并解释其潜在机制:方法:下载miRNA芯片数据集(GSE76774)和mRNA芯片数据集(GSE36221),并进行差异表达分析。对差异表达基因(DEGs)进行了基因本体(GO)功能和京都基因组百科全书(KEGG)通路富集分析。利用 STRING 数据库构建了调控网络中 DEGs 的蛋白质相互作用网络,并通过 Cytoscape 对关键基因进行了筛选。利用 miRWalk3.0 数据库预测了受差异表达 miRNAs(DEMs)调控的潜在下游靶基因,并构建了 miRNA-mRNA 调控网络。最后,对一些研究成果进行了验证:结果:①筛选出4个DEMs和83个DEGs;②GO和KEGG富集分析主要集中在PI3K/Akt信号通路、ECM受体相互作用等方面;③CD2、SLAMF7等可能是GC治疗COPD的关键靶点;④通过mirwalk 3.0数据库预测了18个交叉基因,发现了9对miRNA-mRNA调控网络;⑤地塞米松在COPD细胞模型中上调了miR-320d-2和TFCP2L1的表达,下调了miR-181a-2-3p和SLAMF7的表达:结论:在慢性阻塞性肺病中,GC可能通过miR-181a-2-3p、miR-320d-2、miR-650和miR-155-5p介导PI3K/Akt信号通路的表达,靶向其下游信号因子。这些研究成果为慢性阻塞性肺病的 RNA 治疗策略提供了新思路,也为进一步的研究奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.10
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信